Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558102 · ClinicalTrials.gov registry record
International Retrospective Study of Pipeline Embolization Device
A clinical trial, sponsored by Medtronic Neurovascular Clinical Affairs.
- Completed
- Registry status
- 793
- Enrollment target
NCT01558102 is a clinical trial that has completed, run by Medtronic Neurovascular Clinical Affairs. The registered enrollment target is 793 participants.
The verdict
NCT01558102 has completed, sponsored by Medtronic Neurovascular Clinical Affairs.
- COMPLETED
- Registry status
- 793 participants
- Enrollment target
Study Summary
The primary objective of this retrospective study is to determine the incidence of important safety outcomes in patients who have undergone Pipeline Embolization Device placement for intracranial aneurysms (IAs). This study does not effect patient care, simply it is designed to observe and capture information from numerous hospitals. Data collection will be initiated starting March 2012 and continue until approximately April 2017.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 793 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01558102
The ClinicalTrials.gov registry entry for NCT01558102 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 793 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Neurovascular Clinical Affairs, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01558102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01558102 about?
NCT01558102 is a clinical study titled "International Retrospective Study of Pipeline Embolization Device". The primary objective of this retrospective study is to determine the incidence of important safety outcomes in patients who have undergone Pipeline Embolization Device placement for intracranial aneurysms (IAs). This study does not effect patient care, simply it is designed to observe and capture i...
What is the current status of trial NCT01558102?
This trial is currently completed. The enrollment target is 793 participants. The study started on 2012-03. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01558102?
This trial is sponsored by Medtronic Neurovascular Clinical Affairs, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.